Showing results (331-340 of 496) with videos related to
Sort By:
Pageof 50
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the EvidenceSpencer Phillips Hey, William B Feldman, Emily H Jung, et al.Health Affairs (Project Hope)|December 8, 2011
False Claims Act prosecution did not deter off-label drug use in the case of neurontinAaron S Kesselheim, Devan Darby, David M Studdert, et al.Journal of Substance Use and Addiction Treatment|December 5, 2023
Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015-2019Rachel E Barenie, Brian T Bateman, Hilary S Connery, et al.Neurology|September 30, 2016
Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover studyAaron S Kesselheim, Katsiaryna Bykov, Joshua J Gagne, et al.Plos Medicine|October 22, 2019
Desmopressin and the risk of hyponatremia: A population-based cohort studyMichael Fralick, Sebastian Schneeweiss, Christopher J D Wallis, et al.Health Affairs (Project Hope)|March 6, 2023
Patent Challenges And Litigation On Inhalers For Asthma And COPDSanjay Reddy, Reed F Beall, S Sean Tu, et al.Health Services Research|January 22, 2024
Association between changes in prices and out-of-pocket costs for brand-name clinician-administered drugsHussain S Lalani, Massimilano Russo, Rishi J Desai, et al.JAMA Internal Medicine|May 13, 2024
Patent Portfolios Protecting 10 Top-Selling Prescription DrugsCaroline Horrow, Sarah M E Gabriele, S Sean Tu, et al.Nature Communications|August 2, 2019
Designing development programs for non-traditional antibacterial agentsJohn H Rex, Holly Fernandez Lynch, I Glenn Cohen, et al.Substance Abuse : Research and Treatment|October 6, 2022
Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in MedicaidJohn C Messinger, Aaron S Kesselheim, Seanna M Vine, et al.Pageof 50